Fundz

Mbf Therapeutics, Inc. reported raising $130,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATENov 16, 2017$130K of $1M raised

Amount Raised

$130,000

$130,000 sold, per SEC Form D (first sale Nov 16, 2017)

Round Type

Seed

AmblerBiotechnology

Quick answer

MBF Therapeutics, Inc. raised $130,000 in a Seed round, dated November 16, 2017. MBF Therapeutics, Inc. is based in Ambler, Pennsylvania, United States.

How much did MBF Therapeutics, Inc. raise?
MBF Therapeutics, Inc. raised $130,000 in a Seed round on November 16, 2017.
What does MBF Therapeutics, Inc. do?
MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Max™ immunotherapeutic DNA vaccine platform.
Where is MBF Therapeutics, Inc. based and how big is it?
MBF Therapeutics, Inc. is based in Ambler, Pennsylvania, United States.
Who are the decision-makers at MBF Therapeutics, Inc?
Fundz holds 1 contact at MBF Therapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as MBF Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • ReNetX Bio, Inc. raised $425K (Seed) on December 29, 2017.
  • Okogen raised $6.2M on December 29, 2017.
  • ENDONOVO THERAPEUTICS, INC. raised $700K (Seed) on December 29, 2017.
  • SIWA Biotech Corp. raised $1.4M (Seed) on December 29, 2017.
  • Quadric BioMed raised $74K (Pre-Seed) on December 29, 2017.
  • Imbed Biosciences Inc. raised $1.6M (Seed) on December 28, 2017.

Who to call at MBF Therapeutics, Inc., and when

A new round usually means MBF Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MBF Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MBF Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MBF Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MBF Therapeutics, Inc.

Location

640 WOODBROOK DRIVE

Ambler, Pennsylvania, United States

About

MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Max™ immunotherapeutic DNA vaccine platform. In addition, there are significant translational opportunities in human health. Our T-Max platform addresses longstanding shortcomings of traditional viral vaccine technologies based primarily on killed/inactivated (KWV) whole virus or modified live/attenuated virus vaccines (MLV/AV). Killed virus vaccines have been fairly safe but not efficacious, while MLV vaccine must replicate to generate reasonable efficacy and therefore have significant safety issues for the vaccinated animal and also the herd because of chronic carriers and viral shedding.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MBF Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsThomas T., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MBF Therapeutics, Inc.'s next move

See what Strategic adds

MBF Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.